img

The history of our business

Dr. Paul Janssen started working on the third floor of his parents’ company at Statiestraat in Turnhout in 1953. He was keen to discover the potential effect of chemical substances on a living organism. Together with his first employees, he wanted to create chemical compounds with the intention of patenting them as soon as possible.

1953: Dr. Paul Janssen started his own research in Belgium

Dr. Paul Janssen started working on the third floor of his parents’ company at Statiestraat in Turnhout in 1953. He was keen to discover the potential effect of chemical substances on a living organism. Together with his first employees, he wanted to create chemical compounds with the intention of patenting them as soon as possible.

Dr. Janssen’s first successful discoveries followed soon. The key to his success was his positive dissatisfaction, his unwillingness to accept the ultimate limitations of science, his never-changing openness with regard to new developments and the changes that reveal themselves.

1961: Janssen Pharmaceutica joined the Johnson & Johnson family of companies

Johnson & Johnson expressed a clear interest in acquiring N.V. Laboratoria Pharmaceutica Dr. C. Janssen. In Dr. Janssen’s opinion, this was an excellent opportunity to offer his fast-growing company a life insurance.

In 1961, the two research companies in Turnhout and Beerse, the export company Bepharex and the two Janssen branches in Tilburg (NL) and Düsseldorf (D) came under the management of Johnson & Johnson.

1970-1980

• Screening Janssen compounds for plant protection > azole chemistry;
• Imazalil developed for Cereal seed treatment and Post Harvest;
• Propiconazole found and out-licensed to “Ciba–Geigy” (now Syngenta).

1980-1990: Janssen PMP enters Wood Protection with RODEWOD® and WOCOSEN® product range

Janssen PMP launches their first market entry in 1984 (RODEWOD®), followed by the breakthrough introduction of WOCOSEN® in 1990.

1990-2000: Janssen PMP screens for Antifouling compounds > ECONEA®

• First screening for replacement of TBTO by organic chemistry based actives in 1993;
• 1997: selection of first 2 potent candidates from which ECONEA® was further developed.

2006: Divestment of imazalil business in Seed Treatment and Horticulture

The usage of imazalil infield applications was divested to Certis. However, all developments for the active in post harvest treatment, a core business of Janssen PMP, were retained.

What’s more, Janssen PMP developed several new products:
• PENBOTEC®, that was also successfully introduced in the Unites States;
• PHILABUSTER®, a combination product EUROPE to prevent potential resistance formation in Europe.

2007: Janssen PMP strengthens Microbial Control business through acquisition of PYRION range

Janssen PMP took a next step in broadening their material preservation portfolio and for this acquired the PYRION® product range.

2010: Janssen PMP focuses on Wood Protection, Post Harvest, Antifouling and Microbial Control

 

Contact

Janssen PMP
Turnhoutseweg 30
2340 Beerse
Belgium

Visit

Janssen Pharmaceutica
Johnson & Johnson